Hello and welcome toTitker Trade Network!
Beijing Xiangrui Technology Trading Co., Ltd.

free member

Purchasing agent of sofosbuvir in India, purchase price of hepatitis C drug sofosbuvir, 13621079267

价格 2000.00元/瓶
total supply
1111 瓶
MOQ
1 瓶
area
Beijing
Delivery period:
Shipped within 3 days from the date of payment by the buyer
Buyers are still looking
  • 1
  • 2
  • 3
Products Recommended

Shop information

area:Beijing

Member level:corporate memberYear8

identity:  

Already paid:0.00 yuan deposit

my badge: [Integrity File]

online service:

Business card

Beijing Xiangrui Import and Trade Technology Co., Ltd.

Applets
【Kind tips】When you call, please mention that you saw us on Titker Trade Network, thank you.
Product Details
Sofosbuvir. # is a trend in the treatment of hepatitis C virus. At present, almost all foreign countries use long-acting sofosbuvir, and only in a few cases ordinary sofosbuvir is used. For hepatitis C, the only formal treatment is antiviral treatment<..., that is, sofosbuvir treatment. Through this database, there will be dedicated personnel at the outpatient clinic to check the patient's medication status on a regular basis and notify them of the time to return to the hospital for review and follow-up consultation.
Once diagnosed, active treatment should be given as long as there are no contraindications to sofosbuvir treatment. Those who develop decompensated cirrhosis should undergo conservative treatment or liver transplantation. Because the incidence rate of hepatitis B in China is higher, reaching % in Guangdong alone, the public does not pay attention to hepatitis C. For example, student patients can choose to start treatment during holidays to avoid major events such as marriage, relocation, frequent business trips or tourism.
Regardless of whether the liver function is normal or not, all patients with chronic hepatitis C need to receive antiviral treatment. Patients with decompensated cirrhosis can no longer receive antiviral treatment. To this end, Sun Yat-Sen Third Hospital has set up a hepatitis C expert clinic this year and established a clinical database for hepatitis C patients. Therefore, we would also like to remind many patients here that even if they obtain a good response in the early stage of long-acting sofosbuvir treatment and develop an early virological response, they still cannot stop the drug at will and must continue to complete the treatment for a week. Only in this way can the efficacy be maximized. Choosing a period without major events for treatment can help get through the adaptation period. Long-acting sofosbuvir combined with ribavirin is preferred for sofosbuvir. If ribavirin is not tolerated, sofosbuvir can be used alone.
The harm of viral hepatitis is very serious. Long-term infection can lead to liver cirrhosis and even liver cancer. Many patients often fall into a panic and don’t know what to do. In fact, after suffering from hepatitis C, it is completely unnecessary. Panic, you must know that hepatitis C is completely curable. The most important thing is to be fully familiar with hepatitis C, master the regular treatment methods of hepatitis C, and actively carry out treatment with Indian sofosbuvir.
Polyethylene glycol sofosbuvir (also known as sofosbuvir) uses the latest technology to install an inactive molecule on the sofosbuvir molecule. This not only makes sofosbuvir The molecular weight of sofosbuvir has been increased, which delays the absorption of sofosbuvir, and the molecule can also protect sofosbuvir from direct contact with catabolic enzymes, reducing its clearance rate. This makes it like putting a protective suit on Superman, not only the drug The concentration can be maintained at a stable level, and because the elimination is slowed down, the medication cycle can be greatly extended. The blood concentration is maintained at a relatively ideal level, and the efficacy is also greatly improved. And because the medication interval can be extended from three times a week to once a week, patients' medication compliance can also be significantly improved.
. #At present, hundreds of cases have been accumulated in the database. Patients will be grouped into groups for treatment and follow-up according to the classification of refractory hepatitis C, patients who have reached the prerequisite for treatment, and patients who have not reached the prerequisite for treatment. . Sofosbuvir is divided into ordinary sofosbuvir, first-generation long-acting sofosbuvir, and second-generation long-acting sofosbuvir. The efficacy of long-acting sofosbuvir (or sofosbuvir) in treating hepatitis C is significantly better than that of ordinary sofosbuvir. Adherence to treatment is particularly important. If full-dose treatment is adhered to according to the established course of treatment, the efficacy can be significantly improved and recurrence can be reduced. probability.
In the past, ordinary sofosbuvir, because the molecule was relatively small, was absorbed quickly after subcutaneous injection, and quickly formed a peak in the blood. However, because sofosbuvir lacked a protective device outside the molecule, sofosbuvir was Wei directly comes into contact with the decomposing enzymes in the body and will be quickly eliminated by the body. In order to ensure that a certain therapeutic concentration can be maintained, repeated injections are required, which causes the concentration to fluctuate greatly. The concentration fluctuates greatly. When the concentration is high, Although the therapeutic effect is guaranteed, it also produces many side effects because the concentration is too high. When the concentration is low, the therapeutic effect cannot be achieved, and repeated injections are required, three times a week. This is not only inconvenient to use, but also harmful to the patient's body. The impact is also relatively large. It is hoped that this method can improve the cure rate of hepatitis C by implementing full and standardized management of hepatitis C patients.
The most fundamental treatment goal for infected people is cure. The best indicator for evaluating effective curative treatment is R (sustained virological response, which refers to whether the hepatitis C gene is still negative when reviewed one month after the end of treatment). Liver function within the normal range does not necessarily mean that the hepatitis C virus itself can cause damage to liver cells. As long as the virus exists, this damage will exist. In recent years, studies at home and abroad have found that liver lesions in patients with normal liver function will also progress. Similarly, Liver cirrhosis will turn negative after treatment with Indian sofosbuvir, which can prevent the spread of the disease.
Disclaimer

The information/pictures/parameters, etc. displayed on this webpage about【Purchasing agent of sofosbuvir in India, purchase price of hepatitis C drug sofosbuvir, 13621079267】are provided by member【Beijing Xiangrui Import and Trade Technology Co., Ltd. 】,By Titker Trade Network members 【Beijing Xiangrui Import and Trade Technology Co., Ltd. 】is solely responsible for the authenticity, accuracy and legality of the information/pictures/parameters, etc.,Titker Trade Network only provides display services. For your safety, please choose Titker Trade Network for online trading, otherwise Titker Trade Network will not bear any responsibility for this.

If your legitimate rights and interests have been infringed, please contact Titker Trade Network customer service as soon as possible. We will serve you wholeheartedly. Thank you for your attention and support to Titker Trade Network!

Titker Trade Network